Atualização do Consenso em SMD 2022
DOI:
https://doi.org/10.46765/2675-374X.2023v4n1p178Palavras-chave:
Consenso, Atualização, Neoplasia MielodisplásicaResumo
The document discuss key points in the management of patients with Myelodysplastic Disease, including therapeutic strategies, the role of new drugs available as well the Hematopoietic Stem Cell Transplantation. Other issues evaluated were importance of molecular alterations since diagnosis to prognosis, use of comprehensive geriatric assessment for patient's selection, individualization of treatment, donor selection for HSCT and the role of blasts % and molecular mutations for the appropriate diagnosis.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2023 JBMTCT
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.